Advanced Materials· 2012Q1
Dopamine‐Melanin Colloidal Nanospheres: An Efficient Near‐Infrared Photothermal Therapeutic Agent for In Vivo Cancer Therapy
- 2,001citations
- Q1SCImago
- 2012year
Short summary
Dopamine-melanin colloidal nanospheres demonstrate up to 40% photothermal conversion efficiency, enabling effective in vivo cancer therapy with low power density and short irradiation times.
AI-generated from the title and abstract; the full text is not read.
Key points
- Dopamine-melanin colloidal nanospheres are a new class of photothermal therapeutic agents.
- They possess high biocompatibility and biodegradability.
- Achieve up to 40% photothermal conversion efficiency.
- Successfully damage tumors in vivo at low power density and short irradiation times without harming healthy tissues.
AI-generated from the title and abstract; the full text is not read.
Abstract
A new generation of photothermal therapeutic agents based on biopolymer dopamine-melanin colloidal nanospheres is described. Benefitting from their naturally wide distribution in humans, dopamine-melanin colloidal nanospheres exhibit robust biocompatibility and biodegradability, and provide up to 40% photothermal conversion efficiency. After administration, they can efficiently damage tumors at low power density and short irradiation time without damaging healthy tissues.
The authors' abstract, as published at the source. Advanced Materials, 2012 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Biomedical Engineering
Biomedical EngineeringEngineering